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REVIEW ARTICLE OPEN
Systematic review of association between critical errors in
inhalation and health outcomes in asthma and COPD
Janwillem W. H. Kocks 1, Henry Chrystyn2, Job van der Palen3, Mike Thomas4,5,6, Louisa Yates7, Sarah H. Landis8, Maurice T. Driessen7,
Mugdha Gokhale9, Raj Sharma7 and Mathieu Molimard10
Inhaled medications are the cornerstone of treatment and management of asthma and COPD. However, inhaler device errors are
common among patients and have been linked with reduced symptom control, an increased risk of exacerbations, and increased
healthcare utilisation. These observations have prompted GINA (Global INitiative for Asthma) and GOLD (Global initiative for chronic
Obstructive Lung Disease) to recommend regular assessment of inhaler technique in a bid to improve therapeutic outcomes. To
better deﬁne the relationship between device errors and health outcomes (clinical outcomes, quality of life, and healthcare
utilisation) in asthma and COPD, we conducted a systematic review of the literature, with a particular focus on the methods used to
assess the relationship between device errors and outcomes. Sixteen studies were identiﬁed (12 in patients with asthma, one in
patients with COPD, and three in both asthma and COPD) with varying study designs, endpoints, and patient populations. Most of
the studies reported that inhalation errors were associated with worse disease outcomes in patients with asthma or COPD. Patients
who had a reduction in errors over time had improved outcomes. These ﬁndings suggest that time invested by healthcare
professionals is vital to improving inhalation technique in asthma and COPD patients to improve health outcomes.
npj Primary Care Respiratory Medicine           (2018) 28:43 ; doi:10.1038/s41533-018-0110-x
INTRODUCTION
Asthma and chronic obstructive pulmonary disease (COPD) are
common chronic respiratory diseases that impart an economic
and social burden.1–4 Rates of asthma vary between countries,
affecting 1–18% of the population,5 and >10% of adults aged 40
years and over in the general population are estimated to suffer
from COPD.6
Inhaled medications are the cornerstone of the treatment and
management of asthma and COPD.4,5 There are many devices for
the delivery of inhaled medications, including pressurised
metered-dose inhalers (pMDIs), dry-powder inhalers (DPIs), soft-
mist inhalers, breath-actuated MDIs, and nebulisers4,7; pMDIs and
DPIs are the most commonly used.8,9 While the wide array of
treatments available may be seen as positive, the large number of
available devices can result in a certain amount of complexity for
prescribers when teaching patients their correct use.
Effective use of inhalers requires patients to follow the
prescribed inhalation technique.7,8 Errors in device use can result
in suboptimal drug delivery, reducing the effective medication
dose and thus compromising treatment effectiveness.9–13 In this
systematic literature review, an error is deﬁned as critical if it has
an impact on the effectiveness of the drug. It has been estimated
that up to 92% of patients make at least one critical error when
using an inhaler, with a higher error rate reported in patients with
COPD compared with those with asthma.9 The type and frequency
of errors vary among devices depending on their characteris-
tics,11,14–19 although many common errors are universal, such as
failing to exhale before each inhalation and failing to hold the
breath following inhalation.9 Overall, physicians tend to over-
estimate good inhalation technique and underestimate errors
made by patients.20
It is important, therefore, that effective strategies are in place to
educate patients on correct inhaler use.21 Key guideline groups
such as GINA (Global INitiative for Asthma) and GOLD (Global
initiative for chronic Obstructive Lung Disease) have made
recommendations to monitor inhaler technique in their strategy
documents4,5; for example, the most recent version of GOLD
recommends the assessment and regular evaluation of inhaler
technique, with the aim of improving therapeutic outcomes in
patients with COPD.4 Both GINA and GOLD also recommend that a
patient’s ability to use an inhaler device correctly should be
integral to decision-making when choosing between available
controller medications.4,5
Although there is evidence that errors in device use can affect
outcomes,19 there is no comprehensive overview of the relation-
ship between them. Therefore, this systematic review of the
literature was conducted to examine the relationship between
device errors and health outcomes (clinical, quality of life [QoL],
and economic) in patients with asthma and COPD.
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LITERATURE SEARCH
Systematic searches of PubMed, Google, and Google Scholar were
conducted in April 2017 (updated December 2017) to identify
studies assessing device errors, incorrect handling, or improper
technique in patients with asthma or COPD. Additional studies
were identiﬁed from a recently published systematic literature
review of inhaler device errors9 and by author recommendation.
PubMed was searched using the search string: (COPD OR
chronic obstructive pulmonary disease OR Asthma) AND (error OR
mishandling OR erroneous OR incorrect use OR incorrect
technique OR improper use OR improper technique OR inade-
quate technique OR inadequate use OR insufﬁcient use OR
insufﬁcient technique OR critical error OR signiﬁcant error).
Google and Google Scholar were searched using the following
key terms, in different combinations: (asthma or COPD device
error; device error in asthma or COPD; improper technique in
asthma or COPD; inadequate use in asthma or COPD; misuse or
mishandling in asthma or COPD; incorrect use in asthma or COPD).
Publications that did not report on clinical trials or clinical
studies were excluded from the initial results. Publication titles
and abstracts were then screened, and articles that did not link
device errors with outcomes of asthma or COPD were excluded.
Data were extracted systematically by an independent reviewer
using a predeﬁned extraction template (Supplementary Table 1).
Odds ratios (ORs) were the principal measures of the relationships
between errors and outcomes.
IDENTIFIED STUDIES
Of the screened publications, a total of 19 relevant articles were
identiﬁed (Fig. 1). Seven of these were sourced from the database
searches (PubMed [n= 6], Google/Google Scholar [n= 1]), and a
further seven were identiﬁed from a recent systematic literature
review.9 The remaining ﬁve articles were identiﬁed during data
extraction (n= 2) and data analysis (n= 1), and as a recommen-
dation by one of the investigators (MD) (n= 2).
Of the 19 relevant articles, three were excluded (duplicates
removed [n= 2], judged by investigators to not report relevant
data [n= 1]), leaving a total of 16 unique studies (Fig. 1). These
studies reported associations between device errors and clinical
outcomes, and were included for discussion in the review. Details
of the included studies are shown in Table 1. In general, the
studies examined patients with asthma and COPD separately, with
most (n= 12) studying patients with asthma only (Table 1).
Overall, disease severity was not speciﬁed in the studies. Most
studies included 500 patients or more and focused on adults, with
only a few including adolescent patients or patients of all ages
(Table 1). In one study that included children below 12 years old,
20% were < 16 years old.32 In most studies, patients were recruited
from outpatient clinics, mostly in European countries (Table 1).
MDIs (alone or with a spacer), breath-actuated MDIs (Autohaler
and Easi-Breathe inhaler [trademarks of Teva Pharmaceuticals Ltd])
and DPIs (Diskus [a trademark owned by or licensed to the GSK
group of companies], Turbuhaler [trademark of AstraZeneca Ltd],
HandiHaler [trademark of Boehringer Ingelheim]) were the most
commonly studied inhalers (Table 1).
EXAMINATION OF INHALER ERRORS
Six studies examined critical errors (i.e., the authors speciﬁcally
stated that ‘critical errors’ were evaluated).8,19,23,29,33,35 In the
remaining 10 studies, the term ‘critical errors’ was not used;22,24–
28,30–32,34 however, there was overlap in the actual errors across all
studies. Only one study, CritiKal,19 identiﬁed associations between
speciﬁc inhaler technique errors and reduced disease control,
conﬁrming those errors as critical. Some studies deﬁned errors
separately for each device used by patients.8,19,23,26,28,29 Errors
were generally assessed using checklists for assessment of
inhalation technique.8,19,22–24,26,28,29,31,32,34,35 Overall, a patient’s
technique was judged to be poor (for both critical and non-critical
errors) if any one of the required steps was missed or performed
inaccurately.22,23,26–28 A number of studies in asthma or COPD
identiﬁed inhaler errors that were established as critical errors in
the CritiKal study; these are shown in Table 2.
ASSOCIATIONS BETWEEN DEVICE ERRORS AND OUTCOMES
While most studies demonstrated a cross-sectional association
between errors and outcomes using several approaches, they did
not distinguish between critical and non-critical errors.22,24–28,30–
32,34 Most commonly, errors were deﬁned dichotomously (i.e., any
errors present vs. no errors present), with clinical outcomes
compared in patients with and without inhalation errors.8,19,22–
28,32,33
A less common approach was based on the number of errors
(i.e., association between the number of errors and outcomes22,34).
A few studies focused on speciﬁc devices and/or speciﬁc errors,
and empirically determined the errors that were associated with
adverse outcomes.19,22,32
Among the longitudinal analyses, two approaches were used.
The ﬁrst approach involved demonstrating an improvement in
inhalation technique alongside an improvement in outcomes,
without statistically testing the association,30 whereas the second
approach demonstrated statistical associations between improved
inhalation technique and improved outcomes over a period of
1 month or more.29,31 Prospective studies generally involved
participant training, and before/after comparisons of inhalation
technique and outcomes.29–31 However, two longitudinal studies
examined the evolution in error rate over extended periods of
time (3−4 and ≥ 6 months, respectively30,31).
EFFECT OF DEVICE ERRORS ON OUTCOME MEASURES
Most of the studies assessed the effects of device errors on the
clinical outcome of disease control in asthma and COPD (Table 1).
Measures of asthma control were the Asthma Control Test (ACT; n
= 6),8,26,27,30,31,34 the Asthma Control Questionnaire (ACQ; n=
3),24,29,31 study-speciﬁc questionnaires (n= 3),19,22,23 GINA cate-
gory (n= 2),28,32 Control of Allergic Rhinitis and Asthma Test (n=
1),34 and any unscheduled medical intervention due to respiratory
disease (n= 2).8,19 COPD control was assessed using the modiﬁed
Medical Research Council (mMRC) Dyspnoea Scale (n= 2)8,34 and
the number of COPD exacerbations (n= 1).33 Only one study
evaluated the clinical outcome of QoL in patients with asthma,
reporting the association between device errors and QoL using
the Asthma Quality of Life Questionnaire (AQLQ)31 (Table 1). Six
studies assessed healthcare resource utilisation (HRU) as the
clinical outcome in asthma and/or COPD (Table 1). Economic
outcome measures were emergency room (ER) visits (n=
6),8,22,25,26,33,35 hospitalisations (n= 2),8,35 and prescriptions (anti-
microbial agents, steroids, n= 2)8,35; one study examined costsFig. 1 Flow diagram of the literature search
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associated with increased HRU due to critical errors in both
asthma and COPD patients.35
Key ﬁndings of studies in asthma and COPD are shown in
Supplementary Tables 2 and 3. Data supporting an association
between inhalation errors and worse disease outcomes were
reported in almost all studies, and patients in the longitudinal
studies who had a reduction in errors over time had improved
outcomes, irrespective of endpoint. Despite differences in study
designs across the evaluated studies, the magnitude of effect
appeared to be similar across the different endpoints. For
example, reported ORs of the relationship between device errors
and worse outcomes typically ranged from 1.46 to 1.73 for ACT
score,8 and 1.30 to 1.56 for study-speciﬁc questionnaires assessing
asthma control.19 ORs linking critical inhaler errors to mMRC
Dyspnoea score8 or severe COPD exacerbations (requiring
hospitalisation/ER visit)33 were 1.10 and 1.86, respectively. Two
studies failed to report an association between errors and
outcomes (one in asthma patients,31 and another in the COPD
cohort of a mixed asthma/COPD study34); however, both had small
sample sizes (40 and 27 [COPD] patients, respectively), and were
possibly underpowered.31,34
Inhaler technique, asthma outcomes and treatment adherence
have all been linked to one another34; however, only ﬁve of the
evaluated studies measured treatment adherence, all of which
measured patient-reported adherence.19,23,27,29,33 Giraud et al.29
found that training patients in inhaler technique led to statistically
signiﬁcant improvements in ACQ score, patient-reported adher-
ence, and the number of patients demonstrating optimal
technique (all p < 0.001).
DISCUSSION
The majority of studies identiﬁed from the literature reported an
association between inhalation errors and worse disease out-
comes in patients with asthma or COPD, and the magnitude of
effect was similar across the different endpoints studied. Most of
the studies were cross-sectional and were conducted in pulmo-
nology clinics/outpatient departments. A few prospective, long-
itudinal studies, and some database analyses, were also identiﬁed.
There are advantages and disadvantages to each study design
that should be considered when interpreting the literature. For
example, it is difﬁcult to infer causality using a cross-sectional
approach, due to lack of temporality. This approach can also be
subject to recall bias (especially for HRU studies). In general,
outcome data (e.g., number of hospitalisations, ER visits etc.) in the
identiﬁed studies relied upon retrospective recollection by
patients, and were often limited to events in the recent past (1
−3 months). Furthermore, while database analyses provide readily
available data, few databases capture data on device errors, and as
a result, associated information on inhalation technique. Prospec-
tive studies can overcome the issue of temporality by providing
more reliable data on outcomes, especially those related to HRU.
However, they are operationally more challenging to conduct, and
do not provide results as quickly as cross-sectional or database
analyses. Longitudinal studies, on the other hand, can evaluate the
long-term impact of errors and causality, and are able to address a
variety of research questions. For example, longitudinal studies
can be used to measure the effects of interventions that target
inhaler errors.
Despite guidance by GINA, GOLD, and national asthma and
COPD guidelines, inhaler errors made by patients are still
prevalent, and the type and incidence of errors has not changed
considerably over the past 40 years.36 As little has improved over
the last decade,20 further efforts to support patients in using their
inhaler(s) or an alternative approach to delivering inhaled
medications is needed to resolve this ongoing issue.13 For
example, investing in training time for healthcare professionals
could help to enhance patient support and improve overall
inhalation technique. Efforts have also been made to develop
simpliﬁed regimens with fewer inhalers,13 and to provide inhalers
that are more intuitive to use.37 Both strategies have the potential
to reduce the number of errors made by patients, subsequently
enhancing the effectiveness of the medication and associated
patient outcomes.
Alternative approaches to help patients retain the skills needed
to use their device correctly should also be considered. The recent
development of electronic devices that attach to existing inhalers,
or the development of integrated inhalers that measure inhalation
characteristics, can provide direct feedback to patients on their
inhaler technique. This has the potential to reduce errors, as
previous studies have shown that regular feedback can improve
the retention of correct inhaler technique.13
As treatment adherence has an impact on asthma outcomes,34
and an association has been demonstrated between adherence
and inhaler technique (poor adherence was linked with poor
technique, and good adherence with good technique),29 it is
important to consider the potential for treatment adherence to
amplify associations between device errors and asthma outcomes.
There is a lack of consistency in the literature regarding which
errors are deﬁned as critical. Errors should be assessed using a
single checklist that is standardised as much as possible across the
different devices. One uniﬁed deﬁnition for ‘critical errors’ should
be used; for example, the CritiKal study catalogued errors that
were related to poor asthma control.19 Studies should report
Table 2. Inhaler errors identiﬁed as critical in the CritiKal study19 that had previously been used in other studies
CritiKal study error Number of studies that evaluated the error
Asthma studies COPD studies Both asthma and COPD
Did not remove cap/slide cover open 422,24,26,29 0 18
Insufﬁcient inspiratory effort 519,22,26,28,29 133 134
Did not have head tilted such that chin is slightly upward 219,26 0 0
Did not breathe out to empty lungs before inhalation 519,22,24,26,30 133 18
No breath hold (or holds breath for < 3 s) 719,22,24,26,28–30 133 28,34
Did not seal lips around mouthpiece 519,24,26,28,29 0 18
Incorrect second dose preparation, timing, or inhalation 119 0 0
Exhaled into device before inhalation 219,30 133 0
Dose compromised after preparation because of shaking or tipping (DPIs only) 219,28 0 0
Actuation did not correspond with inhalation, actuation before inhalation (MDI only) 519,22,24,26,29 133 18
COPD chronic obstructive pulmonary disease, DPI dry-powder inhaler, MDI metered-dose inhaler
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errors individually for the various devices in order to identify
persistent problems and better target device training. A recent
systematic review and meta-analysis estimating error rates in MDIs
and DPIs failed to show a difference between various inhalers due
to a relatively limited body of evidence. However, it did conﬁrm
that overall and critical error rates were unacceptably high across
all devices.9 Most of the errors in the CritiKal study were generic to
the type of inhaler (DPI or MDI) rather than device speciﬁc.19
A limitation of this systematic review was that a meta-analysis of
the literature could not be performed due to heterogeneity in
study designs, outcomes, and patient populations studied,
although these may become viable in the future as study designs
become more uniform.
Published data from studies in asthma and COPD demonstrate
the presence of an association between inhalation errors and
outcomes, with an apparent relationship between a reduction in
errors and improvement in outcomes, irrespective of endpoint.
The magnitude of effect is similar across the different endpoints.
Therefore, investment of time by healthcare professionals is vital
to improving inhalation technique in asthma and COPD patients
in order to improve health outcomes. The methodology used to
study the relationship between inhaler errors and outcomes varies
widely. Therefore, there is a need for greater standardisation of
the methods used to assess inhaler errors across the spectrum of
devices and outcome measures. Future research should also focus
on identifying ways to improve device handling.
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